Status: current, Defined. Date: 30-Nov 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4639091000168118 | bemotrizinol + butyl methoxydibenzoylmethane + diethylamino hydroxybenzoyl hexyl benzoate + octocrylene + octyl methoxycinnamate + titanium dioxide (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4639101000168111 | bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | Is a | bemotrizinol + octocrylene + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | true | Inferred relationship | Some | ||
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | Is a | octyl methoxycinnamate + butyl methoxydibenzoylmethane | true | Inferred relationship | Some | ||
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | octyl methoxycinnamate | true | Inferred relationship | Some | 561863801 | |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | diethylamino hydroxybenzoyl hexyl benzoate | true | Inferred relationship | Some | 917571074 | |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | bemotrizinol | true | Inferred relationship | Some | 879380291 | |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | titanium dioxide | true | Inferred relationship | Some | 580111931 | |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | butyl methoxydibenzoylmethane | true | Inferred relationship | Some | 2067155681 | |
| bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | has intended active ingredient | octocrylene | true | Inferred relationship | Some | 318345214 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion | Is a | True | bemotrizinol + butyl methoxydibenzoylmethane + octocrylene + octyl methoxycinnamate + diethylamino hydroxybenzoyl hexyl benzoate + titanium dioxide | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Unit of use quantity reference set
Medicinal product reference set
FHIR